Home / MAA Center / CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval

CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval

A new CAR T-cell therapy for mesothelioma patients has Food and Drug Administration (FDA) approval to begin phase 1 clinical trials. The Atara Biotherapeutics…

from MAA Center https://ift.tt/2GXMSuU
via IFTTT
CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval Reviewed by Unknown on November 12, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.